| Literature DB >> 29932166 |
Agnus M Kim1, Seongcheol Cho2, Hyun Joo Kim3, Min-Woo Jo4, Sang Jun Eun5, Jin Yong Lee6.
Abstract
Korea has experienced an overall expansion of access to care in the past few decades, which necessitated the reconsideration of the role of the public health clinics (PHC) as a primary care provider. The recent controversy about the outpatient copayment waiver for the elderly in the PHC is in the same vein. This study compared the outpatient utilization of the PHC and private clinics, and investigated its factors. Data were acquired from the National Patient Sample in 2013. Compared with private clinics, the patients in the PHC were more elderly and had less severe conditions. Being elderly, the status of National Health Insurance (NHI) beneficiaries, less comorbidities, and low total claim costs were found to be factors for choosing the PHC over private clinics. These results suggest that the elderly, who are the main beneficiaries of copayment waivers in the PHC, are the most likely to use the outpatient service by the PHC. The functions of the PHC need to be rearranged according to the recent advancements in the health care system in Korea. Diverting the resources and efforts from outpatient care to functions that best serve the health of the population should be considered.Entities:
Keywords: Coinsurance; Copayment; Insurance; Korea; Outpatients; Ownership; Primary Care; Public Health Clinic
Mesh:
Year: 2018 PMID: 29932166 PMCID: PMC6068984 DOI: 10.3390/ijerph15071312
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Characteristics of outpatient visits in the public health clinics and private clinics.
| Characteristic | No. of Outpatient Visits (%) | |||
|---|---|---|---|---|
| Total | PHC 1 | Private Clinics | ||
|
| 417,664,423 (100.0) | 11,798,425 (100.0) | 405,865,998 (100.0) | |
|
| ||||
| 0–19 | 77,658,372 (18.6) | 232,464 (2.0) | 77,425,908 (19.1) | <0.001 |
| 20–39 | 70,478,935 (16.9) | 342,464 (2.9) | 70,136,471 (17.3) | |
| 40–64 | 162,393,179 (38.9) | 3,685,685 (31.2) | 158,707,494 (39.1) | |
| >64 | 107,133,938 (25.7) | 7,537,812 (63.9) | 99,596,126 (24.5) | |
|
| ||||
| Female | 244,815,159 (58.0) | 6,900,386 (58.5) | 237,914,773 (58.6) | <0.001 |
| Male | 172,849,264 (41.4) | 4,898,039 (41.5) | 167,951,225 (41.4) | |
|
| ||||
| NHI 2 | 397,902,947 (95.3) | 11,160,933 (94.6) | 386,742,014 (95.3) | <0.001 |
| Medical Aid | 19,761,477 (4.7) | 637,492 (5.4) | 19,123,984 (4.7) | |
|
| ||||
| Metropolitan | 283,169,896 (67.8) | 4,260,084 (36.1) | 278,909,813 (68.7) | <0.001 |
| Non-metropolitan | 134,494,527 (32.2) | 7,538,341 (63.9) | 126,956,186 (31.3) | |
|
| ||||
| Yes | 332,383,732 (79.6) | 8,347,599 (70.8) | 324,036,133 (79.8) | <0.001 |
| No | 85,280,691 (20.4) | 3,450,826 (29.2) | 81,829,865 (20.2) | |
|
| ||||
| 0 | 377,073,942 (90.3) | 11,034,668 (93.5) | 366,039,274 (90.2) | <0.001 |
| 1 and more | 40,590,481 (9.7) | 763,757 (6.5) | 39,826,724 (9.8) | |
| 6,827.9 | 117.9 | 6,710.0 | <0.001 | |
| 5,161.2 | 92.3 | 5,069.0 | <0.001 | |
| 1,666.6 | 16.9 | 1,641.0 | <0.001 | |
1 PHC: Public Health Clinic, 2 NHI: National Health Insurance, 3 USD: United States dollar, 4 SMDG: Small Minor Disease Group, 5 CCI: Charlson comorbidity index, 6 SD: Standard deviation. 7 OOP: Out-of-pocket.
Factors for choosing the public health clinics over private clinics.
| Variable | Adjusted Odds Ratio | 95% Confidence Interval (Lower Limit–Upper Limit) | |
|---|---|---|---|
|
| |||
| 0–19 | 1.00 (Reference) | ||
| 20–39 | 1.71 | 1.68–1.75 | <0.001 |
| 40–64 | 2.82 | 2.79–2.86 | <0.001 |
| >65 | 6.04 | 5.97–6.12 | <0.001 |
|
| |||
| Female | 1.00 (Reference) | ||
| Male | 1.12 | 1.11–1.12 | <0.001 |
|
| |||
| Medical Aid | 1.00 (Reference) | ||
| NHI 1 | 7.06 | 6.96–7.15 | <0.001 |
|
| |||
| Metropolitan area | 1.00 (Reference) | ||
| Non-metropolitan area | 4.48 | 4.48–4.49 | <0.001 |
|
| |||
| 1 or more | 1.00 (Reference) | ||
| 0 | 2.84 | 2.83–2.85 | <0.001 |
|
| |||
| Yes | 1.00 (Reference) | ||
| No | 1.22 | 1.22–1.23 | <0.001 |
|
| |||
| >14.4 | 1.00 (Reference) | ||
| <9.6 | 33.31 | 33.12–33.50 | <0.001 |
| 9.6–11.6 | 5.48 | 5.44–5.51 | <0.001 |
| 11.6–14.4 | 0.29 | 0.28–0.29 | <0.001 |
|
| |||
| >4.0 | 1.00 (Reference) | ||
| <1.3 | 5.97 | 5.94–6.00 | <0.001 |
| 1.3–2.9 | 0.01 | 0.01–0.01 | <0.001 |
| 2.9–4.0 | 0.10 | 0.099–0.101 | <0.001 |
|
| 1.00 (Reference) | ||
|
| 1.46 | 1.43–1.49 | <0.001 |
|
| 2.63 | 2.60–2.67 | <0.001 |
|
| 7.58 | 7.47–7.68 | <0.001 |
NHI: National Health Insurance, 2 CCI: Charlson comorbidity index, 3 SMDG: Small Minor Disease Group, 4 USD: United States dollar, 5 Insurance: Type of health insurance, 6 Age1b: 20–39, 7 Age2c: 40–64, 8 Age3d: >65.
Figure A1Out-of-pocket costs per outpatient visit in the public health clinics and private clinics.
Figure A2Out-of-pocket expense for an outpatient visit and outpatient drugs in the public health clinics and private clinics. This estimate is when the total cost (OOP + NHI reimbursement) is assumed to be $13 USD, and the fee for drugs is assumed to be $9 USD. PHC: public health clinic, OA: The OOP expense for an outpatient visit saved by visiting a PHC rather than a private clinic, AB: The OOP expense for outpatient drugs saved by visiting a PHC rather than a private clinic, BC: The OOP expense for outpatient drugs prescribed for 30 days, which is saved by visiting a PHC rather than a private clinic (in the case of the most commonly prescribed anti-hypertensive drug in Korea in 2017) [39,40], OA’: The waived OOP expense for outpatient visits in the PHC, A’B’: The OOP expense for outpatient drugs, which is later reimbursed to patients or pharmacies, B’C’: The OOP expense for outpatient drugs for 30 days (Six 5-day prescriptions), which is later reimbursed to patients or pharmacies.